What Is the Difference Between MK-4 and MK-7?

MK-4 and MK-7 are two forms of vitamin K2, the vitamin that switches on proteins used by bone and blood vessels. They behave so differently in the body that their doses differ by about a thousandfold. That gap decides which one fits your goal, and which one can upset a blood thinner.

How MK-4 and MK-7 Differ in Structure and Source

Vitamin K2 is a family of fat-soluble compounds that differ by the length of a side chain.1NutriOriginal. Vitamin K2 MK-4 vs MK-7: Differences for Formulators MK-4 has four repeating units in its chain, and MK-7 has seven, which makes it a long-chain form.1NutriOriginal. Vitamin K2 MK-4 vs MK-7: Differences for Formulators

All vitamin K works by attaching chemical groups to certain proteins so they can grab calcium. K1, from leafy greens, mostly serves the liver and blood clotting. K2 forms reach bone and blood vessels more. The ring-shaped head of the molecule does that work and is identical in all K2 forms. The tail mainly affects how the molecule travels and how long it lasts, and a longer tail ties it more tightly to fats.

MK-4 is found in many animal foods such as meat, eggs and dairy, though in small amounts.2Journal of Nutritional Science and Vitaminology. Vitamin K Content of Foods and Dietary Vitamin K Intake in Japanese Young Women Your body also makes its own MK-4 from vitamin K1, the form in leafy greens.3PubMed. Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme An enzyme builds it inside tissues from a piece split off K1.4PubMed. Key Pathways and Regulators of Vitamin K Function and Intermediary Metabolism

MK-7 comes mainly from fermented soy, and natto has about 939 micrograms per 100 grams.2Journal of Nutritional Science and Vitaminology. Vitamin K Content of Foods and Dietary Vitamin K Intake in Japanese Young Women Typical Western diets contain little of it, so MK-7 intake is often low. Cheese and other fermented foods carry some long-chain K2, but mostly other forms and in smaller amounts, so a normal diet is unlikely to supply the MK-7 amounts used in studies.

How Long Each Stays in Your Blood

After a dose, MK-4 levels in the blood drop by half in about 1.5 to 2 hours.5PeerJ. LC–MS/MS quantitative analysis of phylloquinone, menaquinone-4 and menaquinone-7 in the human serum of a healthy population Long-chain forms like MK-7 take around 72 hours to drop by half.5PeerJ. LC–MS/MS quantitative analysis of phylloquinone, menaquinone-4 and menaquinone-7 in the human serum of a healthy population

Because half of an MK-7 dose is still present after three days, each new daily dose adds on top of what remains. Over a few weeks, blood levels climb to a plateau and then stay fairly even from day to day. MK-4 instead rises and falls. This is why MK-7 effects, good or bad, show up after days to weeks of use rather than hours after the first capsule.

It also affects dosing. MK-4 products are often split into several doses a day, while MK-7 once daily keeps levels steady, and a missed MK-7 dose matters less. Both dissolve in fat, so take either with a meal that contains some, such as eggs, cheese, or food cooked in oil.

Tissues hold MK-4 even when little is eaten, partly because the body makes it from K1. In human tissues, MK-4 exceeds K1 in the brain and kidney, matches it in the pancreas, and is low in the liver, heart and lung.6British Journal of Nutrition. Vitamin K status in human tissues: tissue-specific accumulation of phylloquinone and menaquinone-4 In rats, a normal dose of MK-7 raised MK-4 in bone, brain and testis, while the same dose of MK-4 did not.7PubMed Central. MK-7 and Its Effects on Bone Quality and Strength MK-7 may therefore partly work by being turned into MK-4 where it’s needed, though this has been shown only in animals.

A longer stay in the blood is not automatically better. Blood level only measures how long the compound circulates, not how much good it does in bones or arteries. MK-4 may be taken up by tissues quickly and then converted or used, so a low blood level doesn’t mean it failed to arrive.

Which Form Helps Bones

Vitamin K switches on osteocalcin, a bone protein that helps bind calcium into bone. MK-7 activates osteocalcin more effectively than K1.8PubMed Central. REGULATION OF BONE REMODELING BY VITAMIN K2 In women with osteoporosis, 0.5 mg of MK-4 daily increased active osteocalcin, 5 mg worked better, and 45 mg added nothing more.9International Journal for Vitamin and Nutrition Research. Maximal dose-response of vitamin-K2 (menaquinone-4) on undercarboxylated osteocalcin in women with osteoporosis A rise in activated osteocalcin is a marker, not stronger bones, which helps explain why MK-7 results can look good on lab tests yet mixed on scans.

In Japan, 45 mg of MK-4 once daily is a recognized osteoporosis medicine.10PubMed Central. Efficacy of vitamin K on bone fragility: puzzling findings from which we should learn how to design a rigorous study In older people with osteoporosis given calcium, adding 45 mg of MK-4 for two years largely kept bone density stable, while calcium alone lost about 3%.11Life Extension Magazine. Is Vitamin K2 Good For The Bones MK-4 trials have shown fewer fractures and better bone density.10PubMed Central. Efficacy of vitamin K on bone fragility: puzzling findings from which we should learn how to design a rigorous study That dose is roughly 250 times a typical MK-7 capsule, so these are really different kinds of treatment. You can’t reach the studied MK-4 amount by taking extra tablets of an ordinary supplement, since those are usually sold in far lower amounts.

In healthy postmenopausal women, a low daily MK-7 dose for three years slowed bone loss at the spine and hip neck and improved bone strength.12PubMed. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women In women with low bone density, 375 micrograms for a year kept the inner bone structure of the shin from thinning.13PubMed. Vitamin K2 (menaquinone-7) prevents age-related deterioration of trabecular bone microarchitecture at the tibia in postmenopausal women But in a three-year trial of 375 micrograms with calcium and vitamin D in women with low bone density, bone density and structure didn’t differ from placebo.14PubMed. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial

Proven bone protection from MK-7 is inconsistent. Who was studied, what else they took, and which bone sites were measured can all change the outcome. MK-7 looks plausible and low-risk for most people, but unproven as a bone treatment. Neither replaces prescribed osteoporosis treatment, and it’s worth asking your doctor before taking high-dose MK-4.

Which Form Helps Arteries

Vitamin K activates matrix Gla protein, which helps keep calcium out of artery walls. The inactive form measured in blood signals that it hasn’t been switched on, so a fall in it shows K2 is reaching the vessels. In one trial, 180 and 360 micrograms of MK-7 daily cut the inactive form by 31% and 46% in 12 weeks.15PubMed. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein

Stiffness is the outcome most often studied. It is measured by how quickly a pulse travels along an artery, and stiffer arteries are linked with higher heart risk. It can change within months, whereas heart attacks take years to show up in a trial. In postmenopausal women, a year of MK-7 slowed artery stiffening, and those with the stiffest arteries saw lower blood pressure.16European Heart Journal. Beneficial effects of one-year menaquinone-7 supplementation on vascular stiffness and blood pressure in post-menopausal women

In people on kidney dialysis, six months of MK-7 didn’t reduce artery stiffness overall.17PubMed Central. Effect of Menaquinone-7 Supplementation on Arterial Stiffness in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial Within that group, though, people with diabetes did see less stiffening.17PubMed Central. Effect of Menaquinone-7 Supplementation on Arterial Stiffness in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial Dialysis patients have unusually heavy artery calcification, and six months may be too short to change arteries that damaged. A subgroup result alone isn’t conclusive.

Human artery trials center on MK-7. MK-4 vessel findings are early lab work on cells and animals, so don’t buy MK-4 expecting proven heart effects. Changes in a blood marker don’t prove fewer heart attacks, and K2 doesn’t replace blood pressure or cholesterol treatment.

Typical Doses and Reading the Label

A common 45 microgram capsule is below the vessel-study range, so one capsule doesn’t match those trials. The 375 microgram bone dose also sits well above a standard capsule. Reaching studied amounts may mean several capsules or a higher-strength product, and a higher dose raises the stakes for anyone on a blood thinner.

On the bottle, check whether it says MK-4, MK-7 or just K2. Some labels name only vitamin K2, and without knowing which form it is, you can’t judge the dose or how it fits the research. Some products combine both forms, so look at each amount separately.

Units are easy to misread. A microgram is one thousandth of a milligram, so 45 micrograms is 0.045 mg. A bottle showing 45 mg is a thousand times stronger than one showing 45 mcg, though the number is the same.

Purity varies too. MK-7 products all meet the basic standard yet vary widely in unidentified impurities.19PubMed Central. Menaquinone 7 Stability of Formulations and Its Relationship with Purity Profile One synthetic MK-7 had the most, about 5.7% unknown content.19PubMed Central. Menaquinone 7 Stability of Formulations and Its Relationship with Purity Profile Choose brands with third-party testing.

Blood Thinners and Safety

Warfarin works by blocking vitamin K, and its effect is tracked with the INR, the clotting-time number. In volunteers on low-dose anticoagulants, 45 micrograms of MK-7 daily lowered INR by about 40%.18PubMed. Effect of low-dose supplements of menaquinone-7 (vitamin K2 ) on the stability of oral anticoagulant treatment: dose-response relationship in healthy volunteers Just 10 micrograms caused a meaningful INR drop in at least 4 in 10 people.18PubMed. Effect of low-dose supplements of menaquinone-7 (vitamin K2 ) on the stability of oral anticoagulant treatment: dose-response relationship in healthy volunteers People on warfarin should not take MK-7 supplements unless their doctor approves and monitors it.18PubMed. Effect of low-dose supplements of menaquinone-7 (vitamin K2 ) on the stability of oral anticoagulant treatment: dose-response relationship in healthy volunteers

Extra K2 pushes back against warfarin: a drop in INR means blood clots faster, raising the risk of the clots warfarin is meant to prevent. Doses are tuned to a steady vitamin K intake, so a new daily source can throw off the balance. MK-4’s short stay doesn’t make it safe on warfarin.

If you take a blood thinner, tell your doctor or anticoagulant clinic before starting any K2 product, so they can check your clotting more often if it’s approved. Newer blood thinners like apixaban don’t work through vitamin K, but check anyway. Bring the bottle, since the form and dose matter more than the word K2. Don’t stop or change your vitamin K intake suddenly. If your doctor approves it, keep the dose and brand the same so your results stay predictable.

For everyone else, vitamin K has no established upper limit for healthy adults, and toxicity from food forms is not known. High-dose MK-4 is a medicine and should be used under supervision.